ImmuPharma (LSE:IMM) Net Change in Cash : £0.12 Mil (TTM As of Jun. 2023)

View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

ImmuPharma's Net Change in Cash for the six months ended in Jun. 2023 was £-0.46 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2023 was £0.12 Mil.

ImmuPharma Net Change in Cash Historical Data

The historical data trend for ImmuPharma's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuPharma Net Change in Cash Chart

ImmuPharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Change in Cash

Get a 7-Day Free Trial

2.18

-3.55

4.50

-4.21

-0.98

ImmuPharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Net Change in Cash	Get a 7-Day Free Trial															-1.61	-2.60	-1.48	0.57	-0.46

ImmuPharma Net Change in Cash Calculation

ImmuPharma's Net Change in Cash for the fiscal year that ended in Dec. 2022 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-2.347	+	-0.077	+	1.548	+	-0.105
	=	-0.98

ImmuPharma's Net Change in Cash for the quarter that ended in Jun. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.653 + 0.001 + 0.185 + 0.009

= -0.46

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmuPharma Net Change in Cash Related Terms
Thank you for viewing the detailed overview of ImmuPharma's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuPharma (LSE:IMM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Net Change in Cash

Comparable Companies

LSE:ROQ AQSE:PBX LSE:BVX LSE:SAR LSE:SNG LSE:CIZ LSE:BSFA AQSE:INC LSE:VAL LSE:OCTP OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX

Traded in Other Exchanges

IMM.GB:UK 25I:Germany

Address

One Bartholomew Close, London, GBR, EC1A 7BL

Website

https://www.immupharma.co.uk

ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus and a life-threatening autoimmune disease.

ImmuPharma (LSE:IMM) Headlines

No Headlines